Receptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface...
Receptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1 Pipeline Review H1...
View ArticlePANTS Predicting Nonresponse to AntiTNF in Crohn's Disease
The largest prospective study of tumor necrosis factor TNF inhibitor therapy in Crohn's disease estimates drug response and confirms the role that pharmacokinetics and immunogenicity play. Medscape...
View ArticleEPIOMIC EPIDEMIOLOGY SERIES LOWER URINARY TRACT SYMPTOMS FORECAST IN 12 MAJOR...
Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Lower Urinary Tract Symptoms In 12 Major MarketsLower urinary tract symptoms LUTS are a standardised group of symptoms related to...
View ArticleGlobal Crohn's Disease Partnering 2012 to 2018 Report Updated 01032018 Prices...
The Global Crohn's Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare...
View ArticleResearchers Use of Crohn's Drugs in Pregnancy Might Warrant Delayed...
The antitumor necrosis factor TNFalpha drug adalimumab when taken during pregnancy may persist in the offspring's blood for nearly 2 years according to...
View ArticleAbbVie Inc ABBV Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryAbbVie Inc AbbVie is a researchbased biopharmaceutical company that carries out the research development manufacture and commercialization of advanced therapies to treat complex and serious...
View ArticleAbbVie Inc ABBV Medical Equipment Deals and Alliances Profile Report Updated...
SummaryAbbVie Inc AbbVie is a researchbased biopharmaceutical company that carries out the research development manufacture and commercialization of advanced therapies to treat complex and serious...
View ArticleScientists identify genes linked to specific diseases
Statistical methodology developed by University of Queensland UQ researchers is using what is said to be the largest set of multilevel genomic data ever compiled to help scientists pinpoint the genes...
View ArticleGlobal Gastrointestinal Partnering 20122018 Deal trends players and...
Global Gastrointestinal Partnering 2012 to 2018 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2012. Trends...
View ArticleQueens Medical Associates Offers Education in Recognition of March Colorectal...
Queens oncology and hematology center shares insight on protecting from colon cancerNEW YORK PRWEB March 07 2018 March is National Colorectal Cancer Awareness Month and in recognition Queens Medical...
View ArticlePearl Jam's Mike McCready to Be Honored at 2018 MusiCares Concert for Recovery
Benefit Presented by Amazon Music Will Feature Performances by Barrett Martin Duff McKagan Mike Ness Slash Chad Smith and Nancy Wilson at the Showbox in Seattle on Thursday May 10 2018 The MusiCares...
View ArticlePfizer Announces Favorable Outcome of FDA Advisory Committee Meeting on...
Pfizer Inc. announced a positive outcome from todays U.S. Food and Drug Administration FDA Gastrointestinal Drugs Advisory Committee GIDAC meeting. The GIDAC met to discuss Pfizers supplemental New...
View ArticleRedHill Biopharma Ltd RDHL Pharmaceuticals Healthcare Deals and Alliances...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that develops and commercializes small molecule therapeutics in the areas of gastroenterology oncology and inflammation. The...
View ArticleCarcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic...
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5 Pipeline Review H1 2018SummaryCarcinoembryonic Antigen Related Cell...
View ArticleCelltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies...
View ArticleGlobal Autoimmune Partnering 20122018 Deal trends players and financials...
Global Autoimmune Partnering 2012 to 2018 provides the full collection of Autoimmune disease deals signed between the world's pharmaceutical and biotechnology companies since 2012. Trends in Autoimmune...
View ArticleMorphoSys Presents Results for Fiscal Year 2017 news with additional features
DGAPNews MorphoSys AG Key words Final Results13.03.2018 0700 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany March 13 2018 MorphoSys Presents Results for...
View ArticleGalapagos NV GLPG Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryGalapagos NV Galapagos is a biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates targeted at the...
View ArticleInDex Pharmaceuticals Holding AB INDEX Pharmaceuticals Healthcare Deals and...
SummaryInDex Pharmaceuticals Holding AB InDex Pharmaceuticals is a pharmaceutical development company that offers treatments for immunological diseases. The company provides lead compound kappaproct...
View ArticleImmune Pharmaceuticals Inc IMNP Pharmaceuticals Healthcare Deals and...
SummaryImmune Pharmaceuticals Inc Immune Pharma formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer....
View Article